Synopsys, Rocket Companies, On Holding And A Health Care Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Hightower Advisors’ Stephanie Link picked Synopsys, Inc. (NASDAQ:SNPS) as her final trade.

Sunnyvale, California-based Synopsys is scheduled to report results for the first quarter on Wednesday, Feb. 25, after the closing bell.

Analysts expect the company to report quarterly earnings at $3.56 per share on revenue of $2.39 billion.

Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, said he likes Rocket Companies, Inc. (NYSE:RKT) right here.

Barclays analyst Terry Ma, on Jan. 6, maintained Rocket Companies with an Equal-Weight rating and raised the price target from $19 to $22.

Rob Sechan, CEO of NewEdge Wealth, named Gilead Sciences, Inc. (NASDAQ:GILD) as his final trade.

Lending support to his choice, Citigroup analyst Geoff Meacham, on Jan. 27, maintained a Buy rating on Gilead and raised the price target from $140 to $156, while Truist Securities analyst Gregory Renza maintained a Buy rating and boosted the price target from $140 to $145.

Don't forget to check out our premarket coverage here

Jim Lebenthal, partner at Cerity Partners, said On Holding AG (NYSE:ONON) will report earnings in a couple of earnings, and is expected to show great holiday sales.

BTIG analyst Janine Stichter, on Jan. 29, reiterated On Holding with a Buy rating and maintained a $70 price target.

Price Action:

• Rocket Companies shares dipped 13.7% to close at $17.93 on Friday.
• Gilead Sciences shares gained 1.7% to settle at $141.95 during the session.
• On Holding shares rose 0.8% to close at $45.25 on Friday.
• Synopsys shares fell 3.1% to settle at $465.11.

Image: Shutterstock